Altlzesin was lIsed as an induction agent then diluted and administered as a controlled infusion for 60 patients undergoing 66 procedures. Incremental doses of fentanyl were given to provide additional analgesia. There was delayed awakening in 7 patients (12.1%),3 of whom responded rapidly to narcotic reversal with naloxone. Intracerebral pathology and surgical trauma contributed to the slow recovery in the other 4 patients. Evidence is presented that A lthesin infusions reduce the narcotic requirement. A lthesin anaesthesia provides good neurosurgical conditions without delay in recovery.
INTRODUCTION
Althesin has been shown in animal experiments (Pickerodt et al. 1972 ) and in human studies (Turner et af. 1973, Rasmussen, Rosendal and Overgaard 1978) to reduce cerebral metabolism, cerebral blood flow and intracranial pressure. Because of these effects, Althesin should be valuable for neurosurgical anaesthesia. The aim of this study was to evaluate the use of Althesin anaesthesia for patients presenting for neurosurgical (intracranial) operations. METHOD The study was carried out on 60 unsclected patients having intracranial operations. Patients were excluded if there was a known history of atopic disease, drug hypersensitivity or liver disease. Initially the Althesin was infused at a rate of 0.10 ml/kg/hour, later in the study this rate was increased, so that the patients were divided into three groups (Table 1) . Group Rate of Althesin infusion 0.10 mll kg/ hour 0.15 ml/kg/hour 0.20 mllkg/hour Narcotics were omitted from the premedication when there was evidence of raised intracranial pressure, and when atropine was not included in the premedication it was given intravenously at induction. Prior to induction an intravenous infusion was commenced. Anaesthesia was induced with Althesin 40-60 microlitres/kg injected over 60 seconds after an initial dose of narcotic (fentanyl or pethidine), followed by an intubating dose of non-depolarizing relaxant. Increments of the narcotic were given when necessary and prior to intubation an increment (about one quarter of the initial dose) of Althesin was given. An infusion of Althesin was commenced after the induction prior to the surgical incision and continued until the dural closure or about 15-20 minutes prior to skin closure. Sufficient Althesin was made up for one hour's requirements, thus eliminating the risks of accidental overdosage.
All patients were ventilated with nitrous oxide and oxygen (2: 1) and ventilation was controlled to provide mild hypocarbia. Increments of fentanyl and muscle relaxants were given as necessary during the course of anaesthesia.
At the completion of operation, the residual muscle relaxation was reversed with atropine and neostigmine and the patients extubated after adequate spontaneous respiration had returned. All patients were observed in the neurosurgical recovery ward .
The age, weight and sex of the patients in each group are shown ( Table 2 ). Four patients had repeat administrat~o~s of Althesin and one patient had three admllllstrations within 24 days without untoward effects.
RESULTS
Duration of anaesthesia ranged from 25 minutes to 4.5 hours.
The fentanyl dosage at induction is shown in Table 3 . One patient received 50 mg pethidine, 12 patients (18 %) we~e suffici~~t1y drowsy from their poor neurological Co~dItJon or from their premedication, not to reqUire any narcotic at induction. Most patients (65.5 % ) received 50-100 p.g fentanyl. One patient, a known narcotic addict required 400 p.g.
The fentanyl requirements during anaesthesia are shown (Table 4 ). The number of patien.ts not requiring supplementation was least III Group 1 (P < 0.05). The number of patients who required fentanyl was greatest in Gr<;>up 1 (P < ~.01).
Pethidine was not used dunng anaesthesia. Of the 66 procedures, the!e was rapid recovery in 59, such that the I?at~ent.s wer~ able to answer simple questions wlthlll five mlllutes of extubation. In some patients where scalp closure took longer than anticipated, there w~s some evidence of excessively light anaesthesia after the Althesin was ceased and in four of them halothane or fentanyl was required to stop movements III response to surgical stimulation.
There was delayed awakening after cessation of anaesthesia and reversal of muscle relaxants in seven patients (12.1 %). In three p~tients in whom the Althesin was ceased 15 mlllutes prior to skin closure, there was a rapid response to narcotic reversal with naloxone. One of these three had pel'hidine 50 mg at ind~ction and t,,:o increments of fentanyl 50 p.g dunng anaesthesia and naloxone 0.08 mg was required; another had fentanyl 150 p.g at induction and a total of 175 p.g during anaesthesia, awakening was rapid after 0.2 mg naloxone. The third patient was premedicated with omnopon 20 mg and hyoscine 0.4 mg and did not require narcotics at induction. He was given two increments of fentanyl 100p.g during anaesthesia, the second dose prior to the end of operation, he was adequately reversed with naloxone 0.1 mg.
In four patients, narcotics did not appear to be the cause for delayed recovery. It is probable that this was the r~sult of t.heir intracranial pathology. One patIent remallled drowsy and non-respo~sive to vo?al command for 30 minutes foIIowlllg extubatIOn, but then improved and was responsive and talking. Three hours postoperatively he developed hypotension and a deterioration in lev~l of consciousness. He died 12 hours postoperatIvely from irreversible ventricular arrhythmias. Post martem examination revealed residual tumour and associated medullary swelling. One patient was drowsy and confused preoperatively, had obvious lower cranial nerve palsies, was regurgitating and had difficulties in talking. Following extubation he was less responsive than before operation, but his respiration was adequate. By the next day he deteriorated and required ventilatory support and intubation for six days, probably as a result of brain stem oedema. Another patient had an insertion of ventricular-atrial shunt 11 days previously, from which he recovered uneventfully. Following partial removal of his malignant tumour he remained drowsy for 20 minutes after extubation but recovered gradually to his preoperative state. One further patient was drowsy and not responsive for three hours following extubation, then gradually improved. At operation he had a deeply situated meningioma, which was difficult to remove and this was accompanied with an acute blood loss of approximately 1,750 ml, causing a momentary hypotension to 80 mmHg systolic. Except for the brief period of hypotension that occurred in this patient, there were no intraoperative complications to account for the delayed recovery in these four patients.
COMPLICA nONS
There were no complications of any serious nature. There was no pain on injection, no falls of blood pressure which exceeded 20% of the pre-induction level. There was no skin flushing and no evidence of sensitivity reactions. The recovery was smooth and uneventful, postoperative nausea, vomiting and shivering was not noted. When reviewed the next day, there was no evidence of thrombophlebitis. In one patient Althesin was abandoned because the intravenous cannula was required to infuse a solution of sodium nitroprusside.
DISCUSSION
Althesin has an established place in modern anaesthetic practice, not only as a rapid acting induction agent, but as a sole anaesthetic for short procedures, and as an Bdjunct to nitrous oxide for longer operations. In the later circumstance it has been used either as mtermittent bolus injections (Takahashi 1972, J ago and Lestall 1977) , or as a continuous infusion at various dosage rates (DuCailar 1972 , Savage 1975 , Duchene 1977 .
Because of its high therapeutic ratio and lack of accumulation it can be safely given for many hours of anaesthesia without delay in recovery, provided liver function is normal. Ramsay (1974) reports the use of a controlled infusion as a sedative in an intensive therapy unit. Althesin was given as an infusion for periods up to 20 days (mean 93 hours) and there was no evidence of tachyphylaxis or delay in recovery time. One patient received a total dose of 4,367 ml undiluted Alrhesin at a mean dose of 0.2339 ml/kg/hour. Althesin has certain specific advantages in neuroanaesthesia. It markedly reduces cerebral oxygen uptake and this metabolic depression leads to a secondary fall in cerebral blood flow and intracranial pressure (Pickerodt et al. 1972 , Turner et al. 1973 , Rasmussen, Rosendal and Overgaard 1978 . The reduction in intracranial pressure is more marked when the pressure is elevated, e.g. space occupying lesions in the brain. In these respects Althesin resembles barbiturates (Wollman et al. 1967) and differs from ketamine (Gardern, Olson and Lichtiger 1971) and the volatile agents .
Another advantage is that the recovery is smooth, rapid and complete, providing an early opportunity for rhe assessment of neurological functions.
Barbiturates have been used as an infusion for neuroanaesthesia (Hunter 1972a , Hunter 1972b ) but because of the difficulty in assessing dose requirements and the occurrence of delayed recovery, this technique has not been accepted. Dilute narcotic infusions are not popular in neuroanaesthesia because although fentanyl! d roperidol combinations coupled with intermittent positive pressure ventilation reduce cerebrospinal pressure in normal patients, as well as those with space occupying lesions , there may be difficulties in ensuring adequate narcotic reversal and the respiratory depression may be prolonged.
Adverse reactions to Althesin have been documented (Clarke et al. 1975 ) but their true incidence remains controversial (Savege 1977) . Falls in blood pressure at induction can be minimized by using small doses (Savege et al. 1971) , administered slowly into a peripheral vein (McDowall 1972) after hypovolaemia has been corrected (DuCailar 1972) . In fact, the literature contains no report of significant adverse reactions during an Althesin infusion technique.
The reduction of intracranial pressure resulting from a single dose of Althesin 50 p.l/kg will last approximately 10 minutes (Turner et al. 1973 , Rasmussen et al. 1978 ). However, the concentration of an Althesin infusion which will produce and maintain a reduced intracranial pressure has not been investigated. Using the cerebral function monitor (Dubois et al. 1978) , have shown that changes in cerebral activity correlate well with variations in the rate of an AIthesin infusion, and these changes can be used to monitor the level of cortical depression.
The same authors concluded that control of Althesin anaesthesia was easier because AIthesin produces greater variations in the monitor trace. It is a reasonable assumption that Althesin induced falls in intracranial pressure will be dose dependent, and therefore it is probable l'hat the higher dose rate of Althesin will produce greater falls in intracranial pressure and from the experience presented in this paper this did not occur at the expense of delayed recovery. More investigation is needed to evaduate the effects of varying concentrations of AIthesin given over varying times on cerebral activity as evidenced in the electroencephalogram (EEG). This study is currently being undertaken.
Delayed recovery is not uncommon after posterior fossa craniotomy and therefore it is not unexpected that of the four patients that had delayed recoveries, three had posterior fossa exploration in the sitting position.
AIthesin -nitrous oxide oxygen anaesthesia requires less narcotic supplementation than those techniques which do not employ AIthesin. In this study, of the patients that required fentanyl during the course of anaesthesia, there was a significant greater requirement for the patients in Group 1 (P < 0.01). This is in good agreement with DuCailer ( 1972) and further study will be undertaken to investigate this impression.
Concern has been expressed in the literature that Althesin may cause convulsions or may facilitate an epileptic focus (Uppington 1973) in a manner similar to methohexitone (Howells 1968 ). However, Chin, Havill and Rothwell ( 1979) has reported the use of AIthesin in refractory status epilepticus and we have also reported success in a similar case (Saady, Wong and Hicks 1979) .
Ten of the patients reported in this study had convulsions preoperatively and were receiving anti-convulsive therapy. During Anaesthesia and Intensive Care, Vol. VII, No. 2, Ma)" 1979 anaesthesia there was no evidence of any abnormal muscular or convulsive activity. One patient had electrocortography, and there was no evidence of EEG activation. One of these ten patients did have a convulsion within 24 hours postoperatively. He was a known alcoholic who presented with a subdural haemorrhage and a compound depressed skull fracture. He had two convulsions on the morning of the operation, and convulsed mildly once in the recovery room two hours after the Ahhesin had ceased. One patient who did not have preoperative convulsions, did convulse in the recovery room, 2t and 2t hours after the Althesin. As postoperative convulsions in the early postoperative period are a recognized complication of intracranial surgery, this isolated incidence cannot be interpreted as a sequel of Althesin anaesthesia. One patient who was noted to have an epileptic focus on his EEG preoperatively, did not fit in the postoperative period. Therefore, it is concluded from this study that there is no evidence to suggest that any contraindication exists for the use of AIthesin in convulsive states. CONCLUSION Althesin infusions following an Althesin induction as described in this study for neurosurgery provide a very satisfactory anaesthetic technique. It has special desirable effects on intracerebral dynamics, it provides a rapid and smooth recovery, free of complications and would appear to be a valuable technique for neurosurgery.
